Type
. Monocyte-derived soluble suppressor factor(s) in patients with lepromatous leprosy. Infection and immunity. 1983;42(3):890-9.
Type
. [Results of clinico-allergological examination of patients with leprosy]. Vestnik dermatologii i venerologii. 1983;(11):15-8.
Type
. Arogya Agam--place of health. Nursing times. 1983;79(41):27-9.
Type
. Leprosy--a curable disease. 1. Nursing times. 1983;79(40):57-9.
Type
. Hansen's disease and its pedal manifestations. Journal of the American Podiatry Association. 1983;73(8):389-92.
Type
. Status of T and B lymphocytes in peripheral blood. Leprosy in India. 1983;55(3):560-5.
Type
. Effect of dapsone (DDS) on T-cells and their response to PHA and lepromin in tuberculoid leprosy patients. Leprosy in India. 1983;55(3):465-71.
Type
. [Intradermal test using phytohemagglutinin to evaluate the functional activity of T-lymphocytes in leprosy patients]. Vestnik dermatologii i venerologii. 1983;(7):7-9.
Type
. Serum levels of C3-activator (antifactor B) in leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1983;51(2):259-61.
Type
. T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy. Nature. 1983;303(5915):342-4.
Pagination
- Previous page
- Page 1168
- Next page